Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1093192-07-4 | MDL No. : | MFCD16293742 |
Formula : | C11H22N2O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UTWVEOUYCGZORL-SSDOTTSWSA-N |
M.W : | 246.30 | Pubchem ID : | 45382265 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.82 |
Num. rotatable bonds : | 7 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 63.54 |
TPSA : | 90.65 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.4 cm/s |
Log Po/w (iLOGP) : | 2.68 |
Log Po/w (XLOGP3) : | 0.56 |
Log Po/w (WLOGP) : | 0.79 |
Log Po/w (MLOGP) : | 0.61 |
Log Po/w (SILICOS-IT) : | 0.11 |
Consensus Log Po/w : | 0.95 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.26 |
Solubility : | 13.6 mg/ml ; 0.0552 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.04 |
Solubility : | 2.27 mg/ml ; 0.00921 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.43 |
Solubility : | 9.21 mg/ml ; 0.0374 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.96 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With hydrogen In tetrahydrofuran for 2 h; Inert atmosphere | Methyl (2S)-2-amino-3-[(tert-butoxy)carbonyl]amino}-3-methylbutanoate (136): 135 (0.50 g, 1 .4 mmol) is dissolved in anhydrous THF (10 mL) in 50 mL flask and placed under argon. Palladium hydroxide catalyst (0.18 g, 20 wtpercent) is rapidly weight and added to the flask. The flask is then filled with hydrogen and refilled. (-101 kpa). After 2 h, LC/MS showed the reaction is completed. The mixture is filtered through a celite pad, and the filtrate is condensed to dryness. The residue is purified by CombiFlash (eluting with 0-5percent MeOH in DCM) to afford 34 as white solid (330 mg, 95percent yield). 1 H NMR (300 MHz, CDCI3) 51 .30 (s, 3H), 1 .37 (s, 3H), 1 .39 (s, 9H), 3.26 (br s, 2H), 3.71 (s, 3H), 3.87 (s, 1 H), 4.95 (s, 1 H); 13C NMR (75 MHz, CDCI3) δ 24.15, 24.23, 28.55, 52.28, 54.77, 60.55, 79.77, 155.26, 173.41 . |
59.3% | With hydrogen In tetrahydrofuran at 20℃; for 9 h; | Compound III-07 (2.4 g, 6.848 mmol) was dissolved in THF (50 mL), then Pb(OH)2 20percent, 1.3 g) was added. The solution was stirred at room temperature under hydrogen (intensity of pressure: 3.0KG) for 9 h, then filtered and the filtrate was concentrated in vacuo. The residue was purified by chromatography on silica gel with DCM/MeOH (100/1~50/1) to give III-08 (1.0 g, 59.3percent) as a colorless oil. 1H NMR (400 MHz, Chloroform-d) δ 5.03-4.90 (s, 1H), 3.97-3.80 (s, 1H), 3.79-3.70 (s, 3H), 1.52-1.42 (s, 9H), 1.42-1.35 (s, 3H), 1.35-1.28 (s, 3H). MS(EI) m/z: (M+, 246). |
[ 58561-04-9 ]
(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate
Similarity: 0.87